Vision, Integrity, Expertise

Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.

Soligenix has two areas of focus: 1) a therapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as cutaneous T-cell lymphoma, oral mucositis, pediatric Crohn's disease, acute radiation enteritis, and 2) a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, acute radiation syndrome, and emerging and antibiotic resistant infectious disease.

Soligenix Pipeline Diagram

Soligenix Pipeline

View our pipeline

-
slide from the Corporate Presentation

Corporate Presentation
October 15, 2018
View the presentation (pdf)

NORD Summit Posters

Dusquetide poster (pdf)

Ricin Toxin Vaccine poster (pdf)

-
Corporate Fact Sheet
November 2, 2018

View Fact Sheet (pdf)

Soligenix Pipeline Diagram

Soligenix Pipeline

View our pipeline

slide from the Corporate Presentation

Corporate Presentation
October 15, 2018
View the presentation (pdf)

NORD Summit Posters

Dusquetide poster (pdf)

Ricin Toxin Vaccine poster (pdf)

Corporate Fact Sheet
November 2, 2018

View Fact Sheet (pdf)

 
* * Latest News Latest News
 
* * Relevant Publications Publications
Tuesday, December 4th, 2018

Article in Drug Target Review

Monday, November 5th, 2018

Dr. Oreola Donini’s Interview with Nature

Thursday, October 4th, 2018

Soligenix Discusses Ricin Toxin Vaccine

Show more >

 
* * Presentations Presentations

Review of IDR Mechanism of Action and Potential Therapeutic Applications
November 26, 2018

Watch the presentation on YouTube


Thermostabilized Vaccine Development under the Animal Rule: Ricin Toxin Vaccine
November 14, 2018

Watch the presentation on YouTube


Innate defense regulators: Broad-spectrum, host-directed therapy for antibiotic resistant disease
November 13, 2017

Watch the presentation on YouTube

Show more >

* Relevant Publications
Tuesday, December 4th, 2018

Article in Drug Target Review

Monday, November 5th, 2018

Dr. Oreola Donini’s Interview with Nature

Thursday, October 4th, 2018

Soligenix Discusses Ricin Toxin Vaccine

Show more >

* Presentations

Review of IDR Mechanism of Action and Potential Therapeutic Applications
November 26, 2018

Watch the presentation on YouTube


Thermostabilized Vaccine Development under the Animal Rule: Ricin Toxin Vaccine
November 14, 2018

Watch the presentation on YouTube


Innate defense regulators: Broad-spectrum, host-directed therapy for antibiotic resistant disease
November 13, 2017

Watch the presentation on YouTube

Show more >

Our Clinical Trials

Learn more >

Partnering with Us

Learn more >